Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 9 studies | 46% ± 24% | |
retinal cone cell | 7 studies | 48% ± 18% | |
GABAergic neuron | 6 studies | 52% ± 19% | |
mesothelial cell | 5 studies | 37% ± 9% | |
T cell | 4 studies | 20% ± 2% | |
retinal rod cell | 4 studies | 46% ± 17% | |
retinal pigment epithelial cell | 4 studies | 40% ± 17% | |
interneuron | 4 studies | 51% ± 22% | |
CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 34% ± 5% | |
neuron | 3 studies | 26% ± 8% | |
retinal ganglion cell | 3 studies | 35% ± 9% | |
kidney loop of Henle epithelial cell | 3 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 11243.35 | 89 / 89 | 93% | 45.52 | 840 / 901 |
thymus | 97% | 3472.46 | 634 / 653 | 96% | 15.83 | 580 / 605 |
stomach | 62% | 1109.21 | 223 / 359 | 92% | 11.52 | 263 / 286 |
lung | 51% | 672.34 | 297 / 578 | 91% | 14.93 | 1053 / 1155 |
prostate | 44% | 507.27 | 109 / 245 | 94% | 10.80 | 472 / 502 |
esophagus | 39% | 1582.03 | 560 / 1445 | 98% | 18.23 | 179 / 183 |
pancreas | 33% | 331.13 | 107 / 328 | 96% | 15.09 | 171 / 178 |
skin | 72% | 5279.42 | 1297 / 1809 | 53% | 6.35 | 248 / 472 |
intestine | 20% | 251.09 | 191 / 966 | 95% | 10.83 | 502 / 527 |
brain | 82% | 2551.12 | 2169 / 2642 | 33% | 2.71 | 230 / 705 |
bladder | 19% | 163.05 | 4 / 21 | 88% | 12.67 | 441 / 504 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.10 | 29 / 29 |
breast | 4% | 33.81 | 18 / 459 | 94% | 17.12 | 1050 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 98% | 25.89 | 44 / 45 |
adrenal gland | 6% | 71.71 | 15 / 258 | 85% | 23.60 | 196 / 230 |
uterus | 3% | 54.39 | 5 / 170 | 88% | 18.46 | 402 / 459 |
ovary | 7% | 70.71 | 12 / 180 | 77% | 9.43 | 332 / 430 |
liver | 19% | 186.78 | 43 / 226 | 62% | 7.55 | 251 / 406 |
spleen | 71% | 784.89 | 171 / 241 | 0% | 0 | 0 / 0 |
adipose | 33% | 1481.10 | 400 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 32% | 361.91 | 298 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 21% | 2.10 | 17 / 80 |
heart | 6% | 114.64 | 53 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 2% | 29.88 | 23 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 1.35 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0055107 | Biological process | Golgi to secretory granule transport |
GO_0047496 | Biological process | vesicle transport along microtubule |
GO_0031175 | Biological process | neuron projection development |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0034452 | Molecular function | dynactin binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | BICDL1 |
Protein name | BICD family like cargo adaptor 1 BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) (CCDC64A) |
Synonyms | CCDC64 BICDR1 |
Description | FUNCTION: Acts as an adapter protein linking the dynein motor complex to various cargos and converts dynein from a non-processive to a highly processive motor in the presence of dynactin. Facilitates the interaction between dynein and dynactin and activates dynein processivity (the ability to move along a microtubule for a long distance without falling off the track). Predominantly recruits 2 dyneins, which increases both the force and speed of the microtubule motor. Component of secretory vesicle machinery in developing neurons that acts as a regulator of neurite outgrowth. Regulates the secretory vesicle transport by controlling the accumulation of Rab6-containing secretory vesicles in the pericentrosomal region restricting anterograde secretory transport during the early phase of neuronal differentiation, thereby inhibiting neuritogenesis. . |
Accessions | ENST00000546420.5 ENST00000397558.6 [Q6ZP65-1] H0YHW1 ENST00000548673.6 H0YHP2 Q6ZP65 ENST00000547841.1 H0YIC1 |